Management of patients with musculoskeletal back pain and comorbid anxiety

Musculoskeletal back pain (MSBP) is one of the most common reasons for seeking medical care. A socioeconomic burden MSBP significant, as it leads to reduced working capacity adult population. It important consider that chronicity develops under impact “yellow flags”, i. e. factors contribute central sensitization (pathophysiologically) and chronicification (clinically). The factor anxiety underlies development catastrophization, maladaptive escape (“pain”) behaviour, disorders. Anxiety symptoms can be expressed not only in emotional, but also somatic, cognitive behavioural sphere. Timely detection management patients with chronic improves effectiveness syndrome treatment. treatment requires a multidisciplinary approach, which comprises kinesiotherapy, therapy, optimal pharmacotherapy. Evidence-based drugs include non-steroidal anti-inflammatory drugs, such dexketoprofen, prescribed short course at an average therapeutic dose. efficacy safety dexketoprofen syndromes, data from clinical studies systematic review are discussed. authors present their own experience managing patient nonspecific anxiety. flags” led provided. effective approach disorder demonstrated.